Company Myovant Sciences Ltd.
Equities
MYOV
BMG637AM1024
Biotechnology & Medical Research
Business Summary
Number of employees: 579
Managers
Managers | Title | Age | Since |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 21-01-03 |
Adele Gulfo
BRD | Director/Board Member | 61 | 19-12-26 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 19-12-26 |
David C. Marek
CEO | Chief Executive Officer | 59 | 21-01-03 |
Director/Board Member | 59 | 22-10-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 97,235,316 | 46,097,791 ( 47.41 %) | 0 | 47.41 % |
Company contact information
Myovant Sciences Ltd.
11-12 St. James?s Square Suite 1, 3rd Floor
SW1Y 4LB, London
+
http://www.myovant.comSector
1st Jan change | Capi. | |
---|---|---|
+2.06% | 42.59B | |
+7.58% | 40.65B | |
+48.77% | 40.57B | |
-11.96% | 26.77B | |
+8.78% | 24.81B | |
-24.35% | 18.17B | |
+28.24% | 12.05B | |
-3.07% | 11.7B | |
+7.06% | 11.1B |